Efficacy and Tolerance of B-Back (with eleutherococcus senticosus) on Burnout Syndrome
Efficacy and Tolerance of B-Back on the Burnout Syndrome
Enrolment: 87 · Results not recorded
Loading the evidence…
Nutraceutical
1 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Efficacy and Tolerance of B-Back on the Burnout Syndrome
Enrolment: 87 · Results not recorded
Renal Dialysis
Enrolment: 21 · Results not recorded
Caffeine
Enrolment: 30 · Results not recorded
Depression · Stress
Enrolment: 200 · Results not recorded
Cancer · Insomnia · Cancer Related Insomnia
Enrolment: 3000 · Results not recorded
Insomnia Disorders
Enrolment: 40000 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Split-dose whole body irradiation, 4 Gy x 4 (survival) or 3 Gy x 4 (haemogram)
The extract significantly increased survival (p less than 0.001), raised leukocyte counts during days 2 to 12 after the final exposure and reduced cerebral haemorrhage after 4 Gy x 4.
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.